Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EPS (Weighted Average and Diluted): 2021-2024

Historic EPS (Weighted Average and Diluted) for Wave Life Sciences (WVE) over the last 4 years, with Dec 2024 value amounting to -$0.70.

  • Wave Life Sciences' EPS (Weighted Average and Diluted) rose 31.91% to -$0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.65, marking a year-over-year increase of 41.44%. This contributed to the annual value of -$0.70 for FY2024, which is 29.63% down from last year.
  • According to the latest figures from FY2024, Wave Life Sciences' EPS (Weighted Average and Diluted) is -$0.70, which was down 29.63% from -$0.54 recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' EPS (Weighted Average and Diluted) ranged from a high of -$0.54 in FY2023 and a low of -$2.36 during FY2021.
  • For the 3-year period, Wave Life Sciences' EPS (Weighted Average and Diluted) averaged around -$1.10, with its median value being -$0.70 (2024).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 73.66% in 2023, then decreased by 29.63% in 2024.
  • Over the past 4 years, Wave Life Sciences' EPS (Weighted Average and Diluted) (Yearly) stood at -$2.36 in 2021, then rose by 13.14% to -$2.05 in 2022, then spiked by 73.66% to -$0.54 in 2023, then declined by 29.63% to -$0.70 in 2024.